Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,124 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07639450RecruitingPhase 1/Phase 2
N-3C01 Cancer Treatment Study for Advanced Solid Tumors
This trial tests a new drug called N-3C01, alone or combined with immune-boosting medications, in patients whose advanced cancer has stopped responding to standard treatments. The goal is to see if this approach can slow or shrink tumors that have become resistant to other therapies.
Saint Leonards, New South WalesAges 18–75 - NCT07405346Enrolling by invitation
Organoid-guided treatment for advanced leiomyosarcoma
This trial uses your tumor's lab-grown organoids to find the most effective personalized treatment for advanced leiomyosarcoma. It aims to match you with a drug that targets your specific cancer.
Wuhan, HubeiAges 18–75 - NCT07045376Recruiting
Surgical smoke safety training for operating room nurses
This study tests a multi-strategy education program to help operating room nurses learn about the risks of surgical smoke and how to prevent harm. If you are an OR nurse, this training may improve your knowledge and safety habits.
Chiayi City, Puzi CityAges 20 years+ - NCT06666829Recruiting
Personalized rehab with robotics for kids with developmental disabilities
This trial tests a personalized rehabilitation plan that uses new technology and robotic devices to help children and teens with developmental disabilities. The goal is to see if combining these tools can improve daily skills and quality of life.
Genova, GenovaAges 5–21 - NCT06773091RecruitingPhase 1
NK cell therapy for advanced solid tumors
This trial tests an investigational NK cell therapy (NK042) for people with advanced solid tumors that have not responded to standard treatments. The aim is to see if this cellular therapy is safe and potentially effective.
BeijingAges 18–70 - NCT07612995Recruiting
3D Printing Models to Help Students Practice Breathing Tube Placement
This study tests whether using 3D-printed models of airways helps medical students learn to place breathing tubes (endotracheal intubation) more successfully. Researchers will compare traditional training methods with this new 3D printing technology.
Taiyuan, ShaanxiAges Any age - NCT07694869RecruitingPhase 1
Study of ammoxetine tablets in people with moderate kidney problems
This trial tests how a new drug called ammoxetine works in people with moderate kidney impairment compared to those with normal kidney function. It aims to find the right dose and understand how the drug is processed by the body.
Hefei, AnhuiAges 18–75 - NCT07066540Recruiting
Trial of Reamberin for Viral Stomach Infections in Children
This trial tests if the drug Reamberin, given through an IV, can help children aged 1 to 6 recover faster from a viral stomach infection. It's for kids who need fluids through a vein and have symptoms like vomiting, fever, and tiredness.
ChelyabinskAges 1–6 - NCT06223893Recruiting
Smartphone app to improve care after cirrhosis hospitalization
This study tests how well a smartphone app helps people with cirrhosis who have been hospitalized for sudden liver problems. It aims to improve care and access to treatment after you go home.
BirminghamAges 18 years+ - NCT07222085Recruiting
Long-term test of a new myoelectric control strategy
This trial tests a new way to control a powered prosthetic arm called Glide control. Researchers want to see if it stays reliable over time for people who have lost part of their arm below or above the elbow.
Annapolis, MarylandAges 18 years+ - NCT07363967RecruitingPhase 1
Study of SWA1211 for advanced solid tumors
This trial tests a new oral drug, SWA1211, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and works against the cancer.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06506825Recruiting
Stomach Cancer Database Study Using Artificial Intelligence
This trial is building a large database of stomach cancer patients using artificial intelligence to better understand the disease. If you have stomach cancer, you may be able to join and help improve future care.
Shijiazhuang, HebeiAges 18 years+ - NCT06730243Recruiting
New robotic vs. standard surgery for early prostate cancer
This trial compares a new robotic surgical technique (with a special urethra repair) to standard robotic surgery and laparoscopic surgery for men with newly diagnosed prostate cancer that has not spread. The goal is to see which approach best preserves urinary control.
Beijing, Beijing MunicipalityAges 18–80 - NCT07191080Enrolling by invitation
Using advanced genetic testing to diagnose hard-to-find respiratory infections
This study uses a powerful genetic test (next-generation sequencing) to find the cause of respiratory infections when standard tests fail. It may help identify hard-to-detect viruses, bacteria, or fungi in your lung or airway samples.
Nantong, JiangsuAges 18 years+ - NCT06492122RecruitingPhase 1
Study of a radioactive drug for advanced prostate cancer
This trial tests a new radioactive treatment, [225Ac]Ac-FL-020, for men with metastatic castration-resistant prostate cancer (mCRPC) that has gotten worse despite other treatments. It's for those who have had at least one prior hormone therapy or chemotherapy.
Duarte, CaliforniaAges 18 years+ - NCT07327632RecruitingEarly Phase 1
Testing IBI3026 for advanced solid tumors
This study tests a new drug called IBI3026 for people with advanced solid tumors that cannot be surgically removed or have spread. The goal is to see if it is safe and helps control the cancer.
Chengdu, SichuanAges 18 years+ - NCT07555093Recruiting
Micronutrient Supplements and Digital Health Tracking in Pregnancy
This study tests whether taking micronutrient supplements (vitamins and minerals) along with a digital app or text reminders helps pregnant women stay on track with their prenatal care. The goal is to improve nutrition and health outcomes during pregnancy.
Mataram, West Nusa TenggaraAges 14 years+ - NCT07147049RecruitingPhase 2
Testing a new painkiller for moderate to severe pain after surgery
This trial tests a new tablet called HL-1186 for people with moderate to severe pain after certain surgeries. It aims to see if the drug is safe and works well for pain control.
Chengdu, SichuanAges 18–75 - NCT07311369RecruitingPhase 2
Testing a new pain tablet after abdominal surgery
This trial tests a new pain tablet (HL-1186) for people having abdominal surgery. It aims to see if the tablet is safe and works well to manage pain after the operation.
Changsha, HunanAges 18–75 - NCT07107633RecruitingPhase 2
Imaging test for cancer spread in the abdomen
This trial tests a special imaging injection to see if it can better detect cancer that has spread to the lining of the abdomen in people with stomach or bowel cancer. If you are scheduled for surgery to remove or explore the cancer, this scan might help your doctor plan the best treatment.
ShanghaiAges 18 years+ - NCT06713603Recruiting
Digital smoking cessation with motivational counseling
This study tests a digital program that uses personalized counseling over video or phone to help people stop smoking. It is for adults who smoke daily, have a primary care doctor, and can use a smartphone or computer.
San Francisco, CaliforniaAges 18 years+ - NCT07131215Recruiting
Smart technology for health in early menopause
This trial tests whether a smartphone-based program can help monitor and improve the physical and mental health of women who have recently gone through menopause. It aims to see if technology can support healthy lifestyle changes during this transition.
TainanAges 40–65 - NCT07488546Enrolling by invitationPhase 1/Phase 2
HCL001 cell therapy for advanced liver cirrhosis
This trial tests a new cell injection called HCL001 for people with decompensated cirrhosis (advanced liver scarring causing complications). The goal is to see if it's safe and helps improve liver function. It may be an option if you've tried standard treatments and meet specific health criteria.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05653453RecruitingPhase 3
Tumor treatment device plus chemo for locally advanced pancreatic cancer
This trial tests whether a home-wearable tumor-treating device (Tumor Treating Fields) combined with gemcitabine and albumin-bound paclitaxel works better as first treatment for locally advanced pancreatic cancer. It may help by targeting cancer cells while also using standard chemotherapy.
Harbin, HeilongjiangAges 18–75
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,124 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.